Literature DB >> 31867079

Orbital IgG4 Disease: Imaging Findings on 68Ga-DOTANOC PET/CT.

Saurabh Arora1, Nishikant A Damle1, Rachna Meel2, Sanjay Sharma3, Seema Sen4, Chandrasekar Bal1, Kanak Lata1, Sneha Prakash1,5, Divya Yadav1, Meivel Angamuthu1.   

Abstract

Immunoglobulin G4 (IgG4)-related diseases are a spectrum of systemic inflammatory conditions of unknown etiology, which are characterized by infiltration of tissues by IgG4 plasma cells and sclerosing inflammation (Cheuk and Chan Adv Anat Pathol 17:303-32, 2010). Although this condition was initially described in relation to autoimmune pancreatitis, now it has been reported in almost every organ system of body (Zen and Nakanuma Am J Surg Pathol 34:1812-9, 2010, Masaki et al. Ann Rheuma Dis 68:1310-5, 2009). Orbital involvement by IgG4 disease can involve extraocular muscles (EOM), lacrimal glands, conjunctiva, eyelids, infraorbital nerve, orbital fat, and nasolacrimal system (McNab and McKelvie. Ophthal Plast Reconstr Surg 31:167-78, 2015, Katsura et al. Neuroradiology 54:873-82, 2012). The basis of using 68Ga-DOTANOC PET/CT in IgG4 orbital disease is the known expression of somatostatin receptors in chronic inflammatory cells (Cuccurullo et al. Indian J Radiol Imaging 27:509-16, 2017) and also avidity shown previously in other IgG4-related diseases (Cheng et al. Clin Nucl Med 43:773-6, 2018). © Korean Society of Nuclear Medicine 2019.

Entities:  

Keywords:  68Ga-DOTANOC PET/CT; Orbital IgG4 disease; Somatostatin receptors

Year:  2019        PMID: 31867079      PMCID: PMC6898689          DOI: 10.1007/s13139-019-00611-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  9 in total

1.  Radiological features of IgG4-related disease in the head, neck, and brain.

Authors:  Masaki Katsura; Harushi Mori; Akira Kunimatsu; Hiroki Sasaki; Osamu Abe; Toru Machida; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2012-02-23       Impact factor: 2.804

2.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Authors:  Y Masaki; L Dong; N Kurose; K Kitagawa; Y Morikawa; M Yamamoto; H Takahashi; Y Shinomura; K Imai; T Saeki; A Azumi; S Nakada; E Sugiyama; S Matsui; T Origuchi; S Nishiyama; I Nishimori; T Nojima; K Yamada; M Kawano; Y Zen; M Kaneko; K Miyazaki; K Tsubota; K Eguchi; K Tomoda; T Sawaki; T Kawanami; M Tanaka; T Fukushima; S Sugai; H Umehara
Journal:  Ann Rheum Dis       Date:  2008-08-13       Impact factor: 19.103

Review 3.  Diagnostic criteria for IgG4-related ophthalmic disease.

Authors:  Hiroshi Goto; Masayuki Takahira; Masahiro Takahira; Atsushi Azumi
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

Review 4.  IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.

Authors:  Alan A McNab; Penny McKelvie
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 May-Jun       Impact factor: 1.746

Review 5.  IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.

Authors:  Wah Cheuk; John K C Chan
Journal:  Adv Anat Pathol       Date:  2010-09       Impact factor: 3.875

6.  Elevated 68Ga-DOTATATE Activity in IgG4-Related Lymphadenopathy.

Authors:  Zhaoting Cheng; Shuang Song; Yunfeng Han; Sijuan Zou; Xiaohua Zhu
Journal:  Clin Nucl Med       Date:  2018-10       Impact factor: 7.794

7.  IgG4-related disease: a cross-sectional study of 114 cases.

Authors:  Yoh Zen; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

8.  IgG4-Related Perineural Disease.

Authors:  Dai Inoue; Yoh Zen; Yasuharu Sato; Hitoshi Abo; Hiroshi Demachi; Akio Uchiyama; Toshifumi Gabata; Osamu Matsui
Journal:  Int J Rheumatol       Date:  2012-03-18

9.  Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?

Authors:  Vincenzo Cuccurullo; Giuseppe Danilo Di Stasio; Maria Rosaria Prisco; Luigi Mansi
Journal:  Indian J Radiol Imaging       Date:  2017 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.